Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Greco

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
British Journal of Haematology|November 18, 2003
Short progression-free survival in myeloma patients receiving rituximab as maintenance therapy after autologous transplantationPellegrino Musto, Angelo Michele Carella, Michele Mario Greco, et al.
European Journal of Haematology|November 15, 2002
Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yrFelicetto Ferrara, Adriano Venditti, Angelo Michele Carellajr, et al.
Leukemia & Lymphoma|April 4, 2013
Minimal residual disease after allogeneic stem cell transplant: a comparison among multiparametric flow cytometry, Wilms tumor 1 expression and chimerism status (Complete chimerism versus Low Level Mixed Chimerism) in acute leukemiaGiovanni Rossi, Angelo Michele Carella, Maria Marta Minervini, et al.
Leukemia Research|December 16, 2014
Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: a comparison between multiparameter flow cytometry and Wilms' tumor 1 expressionGiovanni Rossi, Angelo Michele Carella, Maria Marta Minervini, et al.
Leukemia Research|August 23, 2005
Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomidePellegrino Musto, Antonietta Falcone, Grazia Sanpaolo, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
British Journal of Haematology|November 18, 2003
Short progression-free survival in myeloma patients receiving rituximab as maintenance therapy after autologous transplantationPellegrino Musto, Angelo Michele Carella, Michele Mario Greco, et al.
European Journal of Haematology|November 15, 2002
Autologous stem-cell transplantation for patients with acute myeloid leukemia aged over 60 yrFelicetto Ferrara, Adriano Venditti, Angelo Michele Carellajr, et al.
Leukemia & Lymphoma|April 4, 2013
Minimal residual disease after allogeneic stem cell transplant: a comparison among multiparametric flow cytometry, Wilms tumor 1 expression and chimerism status (Complete chimerism versus Low Level Mixed Chimerism) in acute leukemiaGiovanni Rossi, Angelo Michele Carella, Maria Marta Minervini, et al.
Leukemia Research|December 16, 2014
Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: a comparison between multiparameter flow cytometry and Wilms' tumor 1 expressionGiovanni Rossi, Angelo Michele Carella, Maria Marta Minervini, et al.
Leukemia Research|August 23, 2005
Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomidePellegrino Musto, Antonietta Falcone, Grazia Sanpaolo, et al.
Pageof 4